A bold truth hits at the heart of this World AIDS Day message: expanding access to the newest WHO-approved tools and boosting investment in services is essential to bend the HIV curve and shield health systems from the fallout of funding cuts. Yet here’s where the controversy begins—without rapid, widespread adoption, progress stalls and risks backsliding.
The World Health Organization is urging governments and partners to accelerate the rollout of fresh prevention options, including lenacapavir, to reduce new infections and mitigate disruptions to vital health services caused by reductions in foreign aid.
This year has seen sharp, abrupt drops in international funding, which have disrupted HIV prevention, treatment, and testing programs. Community-led efforts—such as PrEP access and harm reduction services for people who inject drugs—have already faced scaling back or complete shutdowns in several countries.
We confront a real challenge: funding cuts are eroding prevention gains, but there are significant opportunities on the horizon. Dr. Tedros Adhanom Ghebreyesus, the WHO Director-General, emphasizes that while funding gaps threaten momentum, the arrival of powerful new tools offers a chance to alter the epidemic’s course. The priority is clear: broaden access to these innovations for people at risk of HIV, everywhere, as swiftly as possible.
World AIDS Day is being observed under the theme “Overcoming disruption, transforming the AIDS response.” The WHO advocates a dual-track strategy that combines solidarity with bold investments in new technologies to protect and empower communities most vulnerable to HIV.
For a complete statement from the WHO, read the full release here: https://www.who.int/news/item/01-12-2025-new-prevention-tools-and-investment-in-services-essential-in-the-fight-against-aids.
End of content.
